Our results provide evidence that the NAFLD status further exacerbated with inflammation to develop NASH in WT mice, as evidenced by the significantly higher expression of TNFalpha and IL-6 in WT mice compared to the L-ChREBP-KO group. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.